跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 122 条关于
“Dyno-9zh”
全部
122
临床试验
18
药物
76
机构
1
资讯
27
5个月前
Astellas Licenses AI-Designed AAV Capsid from Dyno Therapeutics for Skeletal Muscle Gene Therapy
10个月前
Dyno Therapeutics Unveils AI-Engineered AAV Vector Dyno-bn8 for Muscle Gene Therapy with 25-Fold Dose Reduction
去年
Dyno Therapeutics Unveils Three AI-Designed AAV Capsids for Enhanced Gene Therapy Delivery
10个月前
Dyno Therapeutics and Trisk Bio Form Strategic Manufacturing Partnership to Accelerate Gene Therapy Development
去年
Roche and Dyno Therapeutics Form $1B+ Alliance to Develop AI-Powered Gene Therapies for Neurological Disorders
去年
Amgen Launches Eylea Biosimilar Pavblu at Discount; GSK Invests $800M in Manufacturing
去年
Roche Discontinues Hemophilia A Gene Therapy Development, Shifts Focus to Enhanced Function FVIII Variant
10个月前
Roche Partners with Manifold Bio in $2B+ AI-Driven Deal to Overcome Blood-Brain Barrier for Neurological Diseases
上个月
AI Protein Design Market to Reach $13.70 Billion by 2035 as Generative Models Reshape Drug Discovery
去年
Dyne Therapeutics' DYNE-101 Receives FDA Fast Track Designation for Myotonic Dystrophy Type 1
第 1 页,共 3 页
上一页
下一页